Last update:

Diseases, Conditions, Syndromes news

Medical research

Synthetic peptide acts as molecular shield to prevent SARS-CoV-2 from infecting cells

A peptide synthesized by researchers at the University of São Paulo (USP) in Brazil protected human lung cells against infection by SARS-CoV-2 in the laboratory and eliminated the inflammation caused by the virus in mice ...

Diseases, Conditions, Syndromes

Viruses found hiding in lungs' immune cells long after initial illness

Doctors have long known that children who become seriously ill with certain respiratory viruses such as respiratory syncytial virus (RSV) are at elevated risk of developing asthma later in life. What they haven't known is ...

Medications

FDA approves Dupixent for chronic obstructive pulmonary disease

The U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic ...

Diseases, Conditions, Syndromes

Toll in Rwanda Marburg outbreak rises to 11

Five more people in Rwanda have died of the deadly Ebola-like Marburg disease, bringing the number of fatalities to 11, the health ministry said late Tuesday.

Diseases, Conditions, Syndromes

Mpox vaccination drive delayed in DR Congo

The mpox vaccination campaign in Democratic Republic of Congo has been pushed back, health authorities told AFP on Tuesday, with the exact start date unclear.

Diseases, Conditions, Syndromes

Creating a more accurate model of inflammatory bowel disease

A research team led by Junior Associate Professor Kazuo Takayama, from the Department of Cell Growth and Differentiation, recently constructed a new model of inflammatory bowel disease using iPS cells that enables more accurate ...

Diseases, Conditions, Syndromes

US investigating potential human-to-human bird flu transmission

Health authorities in the U.S. are studying seven people who developed influenza symptoms after being exposed to a Missouri bird flu patient, raising the possibility of the first human-to-human transmission of the infection.

Diseases, Conditions, Syndromes

Home-based phototherapy as effective as office-based for psoriasis

For plaque or guttate psoriasis, home-based narrowband ultraviolet B phototherapy is as effective as office-based phototherapy, according to a study published online Sept. 25 in JAMA Dermatology to coincide with the annual ...

Diseases, Conditions, Syndromes

New sepsis test provides faster and reliable results

Every year some 49 million cases of sepsis occur, and 11 million sepsis-related deaths occurred worldwide in 2017, according to a study reported by the WHO. This accounts for 20% of all global deaths.

Medications

Cefepime-taniborbactam superior to meropenem for complicated UTI

For adults with complicated urinary tract infection (UTI), including acute pyelonephritis, cefepime-taniborbactam is superior to meropenem, according to a study published in the Feb. 15 issue of the New England Journal of ...

Medications

FDA approves iloprost for severe frostbite

Aurlumyn (iloprost), a vasodilator, has been approved by the U.S. Food and Drug Administration to treat severe frostbite. The injected medication lowers the risk for finger or toe amputation.

Diseases, Conditions, Syndromes

Filter study dispels common myths about Valley fever

A new study of Valley fever spores collected from air filters around the Phoenix metro area is helping a research team led by scientists from the Translational Genomics Research Institute (TGen), part of City of Hope, dispel ...

Diseases, Conditions, Syndromes

CDC may consider loosening COVID isolation guidance

New, proposed guidance being weighed by the U.S. Centers for Disease Control and Prevention recommends that Americans who test positive for COVID-19 no longer need to routinely stay home for five days.

Diseases, Conditions, Syndromes

Study shows rapid COVID-19 tests done at home are reliable

In a study involving nearly 1,000 patients seen at the Baltimore Convention Center Field Hospital (BCCFH) during a five-month period in 2022—researchers at Johns Hopkins Medicine, the University of Maryland School of Medicine ...